Publications

Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.

Holt F. et al, (2024), Clin Oncol (R Coll Radiol), 36, e322 - e332

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.

Holt F. et al, (2023), Int J Radiat Oncol Biol Phys, 117, 869 - 882

Authors' reply to Oke and Welch.

Darby SC. et al, (2023), BMJ, 382

Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy?

Kirby AM. et al, (2023), BMJ, 381

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk None. and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) None., (2023), Lancet, 401, 1277 - 1292

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.

Kerr AJ. et al, (2022), Cancer Treat Rev, 105

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2022), Lancet Oncol, 23, 382 - 392

Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.

Duane FK. et al, (2021), Radiother Oncol, 164, 261 - 267

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150

Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.

Henson KE. et al, (2020), Int J Cancer, 147, 1437 - 1449

Heart failure after treatment for breast cancer

Taylor C. and DARBY S., (2019), European Journal of Heart Failure

International Variation in Criteria for Internal Mammary Chain Radiotherapy.

Duane FK. et al, (2019), Clin Oncol (R Coll Radiol), 31, 453 - 461

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer.

Boekel NB. et al, (2018), Br J Cancer, 119, 408 - 418

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015.

Aznar MC. et al, (2018), Radiother Oncol, 126, 148 - 154

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H. et al, (2017), N Engl J Med, 377, 1836 - 1846

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

Taylor C. et al, (2017), J Clin Oncol, 35, 1641 - 1649

A cardiac contouring atlas for radiotherapy.

Duane F. et al, (2017), Radiother Oncol, 122, 416 - 422

The global burden of women's cancers: a grand challenge in global health

Ginsburg O. et al, (2017), The Lancet, 389, 847 - 860

Cookies on this website

Publications